Abstract:Abstract Background: Influenza virus matrix protein M1 is encoded by viral RNA fragment 7 and is the most abundant protein in virus particles. M1 is expressed in the late stages of viral replication and exerts functionality by inhibiting viral transcription. The M1 protein sequence is an attractive target for antibody drugs. Methods: The M1 protein sequence was amplified by RT-PCR using cDNA from the H5N1 virus as a template; the M1 protein was then expressed and purified. A human strain, high affinity, and single chain antibody (HuScFv) against M1 protein was obtained by phage antibody library screening using M1 as an antigen. A recombinant TAT-HuScFv protein was expressed by fusion with the TAT protein transduction domain (PTD) gene of HIV to prepare a human intracellular antibody against avian influenza virus. The differences between HuScFv and TAT-HUScFv were verified by various experiments and the amino acid binding site of the M1 protein was determined. Results: The M1 protein of H5N1, HuScFv, and TAT-HuScFv, were successfully purified and expressed by and in E. coli . Further analysis demonstrated that TAT-HuScFv inhibited the hemagglutination activity of the 300TCID 50 H1N1 virus, thus providing preliminary validation of the universality of the antibody. After two rounds of M1 protein decomposition, the TAT-HuScFv antigen binding site was identified as Alanine (A) at position 239. Collectively, our data describe a recombinant antibody with high binding activity against the conserved sequences of avian influenza viruses. This intracellular recombinant antibody blocked the M1 protein that infected intracellular viruses, thus inhibiting the replication and reproduction of H5N1 viruses. Conclusion: Recombinant HuScFv was successfully identified using the Tomlinson (I+J) phage antibody library and successfully linked to the TAT protein transductive domain of the HIV virus. Compared with the HuScFv, the addition of the TAT peptide improved its ability to penetrate the cell membrane. A definite amino acid binding site was identified after the decomposition of M1 protein, thus providing a target and reference for the development of antibody drugs and the study of new drugs.

Construction of Single Chain Antibody Library Against Nucleoprotein of Influenza Virus A

Construction of a human scFv antibody library with VH regions randomized and its application

Construction of a Phage Display Library of Human Single-Chain Fv Antibodies from Peripheral Blood Lymphocytes of People with Positive Serum Antibody Against Hepatitis B Virus Core Protein

Preparation and identification of antibodies targeting influenza A virus N1 subtype neuraminidase

Construction and Screening of a Phage Display Library of Repertoire Single Chain Antibody from Mouse Immunized with Vwf-A1

Construction and Screening of Human Immunized Phage-Display Antibody Libraries Against Rabies Virus

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction of Phage Display Library of Single-Chain Fv Antibodies Against Recombinant Human TNF-α

Construction and preliminary identification of a large Nayve human antibody library

Construction of Murine Phage Antibody Library and Selection of Ricin-Specific Single-Chain Antibodies

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Construction and screening of mouse phage antibody libraries against the surface antigens of human T lymphocytes

Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virus

Preparation and identification of a single domain antibody specific for adenovirus vectors and its application to the immunoaffinity purification of adenoviruses

Preparation and identification of a broad-spectrum antibody targeting hemagglutinin protein of influenza A virus

An Intracellular Human Single Chain Antibody to Matrix Protein (M1) of H5N1 Virus

Generation and Characterization of Monoclonal Antibodies Against the Hemagglutinin of H3N2 Influenza A Viruses.

Identification of broad-spectrum neutralizing antibodies against influenza A virus and evaluation of their prophylactic efficacy in mice

Identification and Analysis of B Cell Epitopes of Hemagglutinin of H1N1 Influenza Virus.

Construction of Expression Vectors and Study on Single-Chain Antibody and Reshaping Single-Domain Antibody Against CD3

A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP Recombination